DC Role: 
Project Partner
1 Jan 2017 - 31 Dec 2021
Marie Skłodowska-Curie Action - Innovative Training Network (H2020)


The Marie Skłodowska-Curie Innovative Training Network in3 aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial safety assessment. State-of-the-art human induced pluripotent stem cells research, cheminformatics, mechanistic toxicology and biokinetics are integrated safety assessment approaches. DC is hosting one of the 15 PhD students working on data management and integration, harmonization of analysis workflows and biomarker identification for key events of adverse outcome pathways. Recruitment for this and other positions in the network is still ongoing.

Latest Tweets

Douglas Connect (3 days ago)
RT @eNanoMapper: the first tutorial is migrated from Word/OpenOffice to Markdown! :)
Douglas Connect (6 days ago)
RT @barryhardy: @DouglasConn Poster 783 by @dramaziz of An integrated testing strategy for quantitative #skin #sensitization #risk #assessm…
Douglas Connect (6 days ago)
DC provides an open implementation of the integrated testing strategy (ITS) that assesses skin sensitisation. Our I…
Douglas Connect (1 week ago)
Jeff Wiseman is our first large Toblerone winner at SOT-ToxExpo 2018 🙂 you can stop by Booth (#1669) for a data cou…
Douglas Connect (1 week ago)
EU_ToxRisk & Douglas Connect adopt data API and data explorer concept for internal data sharing. Stop by Booth 1669…

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
  • Phone: +41 61 851 0170
  • Email: